Research summary
Cardiovascular disease is a leading cause of illness and death, but many gaps remain when it comes to optimizing treatments and surgical outcomes. Dr. Subodh Verma, Canada Research Chair in Cardiovascular Surgery, is advancing clinical trials and regenerative medicine to improve patient care in this field.
He and his research team are studying how to improve the longevity of bypass grafts and reduce pain after surgery. They are also evaluating new drug treatments for heart failure and assessing bleeding risks in emergency surgery. In addition, they are using cutting-edge techniques to study regenerative cell exhaustion—a phenomenon in which the body’s ability to repair damaged blood vessels declines over time. By exploring how regenerative cell function differs across populations, and how protective drugs may enhance their effectiveness, Verma’s research is laying the foundation for personalized cardiovascular treatments. Ultimately, this will ensure better outcomes for heart disease patients worldwide.